A Pilot Study on Proteomic Predictors of Mortality in Stable COPD
Proteomic predictors of mortality in COPD and their connection to respiratory, cardiovascular, and cancer-related deaths
Can Proteomic Predictors of Mortality Help Forecast Outcomes in Stable COPD?
Most of the long-term deaths are attributable to respiratory causes, with lower percentages attributed to cardiovascular/cerebrovascular events or cancer.
It is worth nothing that a trend toward better prognoses (disease progression, exacerbations, and mortality) has been observed in the last few years.
This phenomenon may be due to recent changes in treatment and involves the need for new studies on the current predictors of mortality.
Studying proteomic predictors of mortality in COPD to improve survival prognosis
Therefore, the objective of this pilot study was to identify proteomic markers and specific multiprotein signatures that could be useful in predicting long-term mortality, identifying the related pathways and contributing to our knowledge on the mechanisms linked to a poor prognosis for COPD patients.
Proteomic predictors of mortality in COPD: Understanding the biological mechanisms involved in future deaths in long-term patients
A proteomic blood signature found in stable COPD patients can help in establishing their long-term (4-year) survival prognosis.
The most important elements for establishing this prognosis are proteins/peptides linked to the hemostatic and inflammatory statuses during the stable phase, as well as different elements of the immune response.
Furthermore, the present results may help us to better understand the biological mechanisms involved in future deaths in long-term patients.
Authors
Cesar Jessé Enríquez-Rodríguez, Carme Casadevall, Rosa Faner, Sergi Pascual-Guardia, Ady Castro-Acosta, José Luis López-Campos, Germán Peces-Barba, Luis Seijo, Oswaldo Antonio Caguana-Vélez, Eduard Monsó, Diego Rodríguez-Chiaradia, Esther Barreiro, Borja G. Cosío, Alvar Agustí, Joaquim Gea and on behalf of the BIOMEPOC Group
Read more details at
Fecha de publicación
Published: 14 August 2024
Categorías asociadas al artículo
Noticias relacionadas
General population-based lung function trajectories over the life course: an accelerated cohort study
Empirical life course lung function trajectories from ages 4–80 using data from eight cohort studies in Europe and Australia.
Residential greenspace and lung function throughout childhood and adolescence in five European birth cohorts. A CADSET initiative
Study of five European cohorts found no association between residential greenness or urban green space and lung function throughout childhood and adolescence.
Alteraciones espirométricas y sus factores de riesgo en la población joven ambulatoria
Un estudio reciente en Osona (Cataluña) refleja que 20,7% de jóvenes presenta alteraciones espirométricas. También revela síntomas y factores de riesgo en la población joven ambulatoria.
II edición RESPrimaria, 7 de mayo de 2025
No te pierdas la II edición RESPrimaria el próximo 7 de mayo. Inscríbete en formato Streaming o solicita tu invitación presencial. ¡Plazas limitadas!
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry to diagnose of COPD
Siprometry to diagnose COPD: GOLD 2025 recommends using pre-BD spirometry to rule out COPD and post-BD to confirm, ensuring volume responders are not overlooked.
Occluding mucous airway plugs in patients with obstructive lung diseases: a new treatable trait?
Airway mucous plugging is associated with exacerbations, lung function decline, and mortality in COPD, asthma, and bronchiectasis. Identifying it as a treatable trait may improve patient outcomes through airway clearance techniques and pharmacological strategies.
Imagen desarrollada DALL·E, Canva y Diseño gráfico